IGM BIOSCIENCES INC (IGMS)

US4495851085 - Common Stock

15  +1.11 (+7.99%)

After market: 15 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

IGM BIOSCIENCES INC

NASDAQ:IGMS (10/11/2024, 8:05:58 PM)

After market: 15 0 (0%)

15

+1.11 (+7.99%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month63.76%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap889.80M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

IGMS Daily chart

Company Profile

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. The company is headquartered in Mountain View, California and currently employs 216 full-time employees. The company went IPO on 2019-09-18. The firm is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only two binding sites. The company is also focused on creating, developing, manufacturing, and commercializing IgM antibody agonists against oncology and immunology and inflammation targets. The Company’s development programs include Aplitabart, Imvotamab, and IGM-2644. Aplitabart is an IgM antibody targeting Death Receptor 5 (DR5) proteins, being evaluated in multiple phase I combination trials for the treatment of colorectal cancer. Imvotamab is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins. IGM-2644 is a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins.

Company Info

IGM BIOSCIENCES INC

325 E Middlefield Rd

Mountain View CALIFORNIA 94043

P: 16509657873

CEO: Fred Schwarzer

Employees: 204

Website: https://igmbio.com/

IGMS News

ChartMill News Image11 days ago - ChartmillWhich stocks are moving before the opening bell on Wednesday?

Wednesday's pre-market session: top gainers and losers

News Image12 days ago - Investor's Business DailyTop 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover

The company is making a complete shift out of oncology and into autoimmune diseases.

ChartMill News Image12 days ago - ChartmillWhich stocks are moving before the opening bell on Tuesday?

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

ChartMill News Image13 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.

Which stocks are moving after the closing bell on Monday?

News Image13 days ago - IGM Biosciences, Inc.IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
News Image13 days ago - IGM Biosciences, Inc.IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity

– Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis...

IGMS Twits

Here you can normally see the latest stock twits on IGMS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example